Skip to content
10-K

Annual Report

Biofrontera Inc. BFRI BFRIW

0001493152-26-011625

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 16, 2026 11.65M sh
Shares Diluted FY 2025 · Dec 31, 2025 10.17M sh
Shares Diluted FY 2025 · Dec 31, 2024 5.52M sh
Capex FY 2025 · Dec 31, 2025 $2K
Capex FY 2025 · Dec 31, 2024 $10K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$13.36M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$10.27M
Cash And Equivalents FY 2025 · Dec 31, 2025 $6.39M
Cash And Equivalents FY 2025 · Dec 31, 2024 $5.91M
Stockholders Equity FY 2025 · Dec 31, 2025 $10.48M
Stockholders Equity FY 2025 · Dec 31, 2024 $4.43M
Stockholders Equity FY 2025 · Dec 31, 2023 $4.79M
Current Liabilities FY 2025 · Dec 31, 2025 $11.9M
Current Liabilities FY 2025 · Dec 31, 2024 $12.02M
Total Liabilities FY 2025 · Dec 31, 2025 $18.08M
Total Liabilities FY 2025 · Dec 31, 2024 $17.67M
Current Assets FY 2025 · Dec 31, 2025 $18.08M
Current Assets FY 2025 · Dec 31, 2024 $20.7M
Total Assets FY 2025 · Dec 31, 2025 $28.56M
Total Assets FY 2025 · Dec 31, 2024 $22.1M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.04
Eps Diluted FY 2025 · Dec 31, 2024 −$3.22
Eps Basic FY 2025 · Dec 31, 2025 −$1.04
Eps Basic FY 2025 · Dec 31, 2024 −$3.22
Sga Expense FY 2025 · Dec 31, 2025 $37.75M
Sga Expense FY 2025 · Dec 31, 2024 $33.79M
Rd Expense FY 2025 · Dec 31, 2025 $3.72M
Rd Expense FY 2025 · Dec 31, 2024 $2.09M
Net Income FY 2025 · Dec 31, 2025 −$10.54M
Net Income FY 2025 · Dec 31, 2024 −$17.76M
Operating Income FY 2025 · Dec 31, 2025 −$11.35M
Operating Income FY 2025 · Dec 31, 2024 −$17.21M
Revenue FY 2025 · Dec 31, 2025 $41.71M
Revenue FY 2025 · Dec 31, 2024 $37.32M